We are thrilled to share that our latest research paper, titled “Exploring the Potential of Ribes nigrum L., Aronia melanocarpa (Michx.) Elliott, and Sambucus nigra L. Fruit Polyphenol-Rich Composition and Metformin Synergy in Type 2 Diabetes Management”, has been published in the prestigious Journal of Diabetes Research.
This publication is the result of our ongoing MetAron project, “Development of natural-based products, extracts rich in polyphenolic compounds supporting the treatment of diabetes” (POIR.01.01.01-00-0164/19), funded by the National Center for Research and Development. The project’s primary objective is to create a novel blend of extracts rich in polyphenolic compounds that can effectively regulate lipid and carbohydrate metabolism, both of which are often disrupted in individuals with Type 2 diabetes.
Our research specifically focuses on harnessing the natural power of Ribes nigrum L. (black currant), Aronia melanocarpa (black chokeberry), and Sambucus nigra L. (elderberry) to enhance the therapeutic effects of metformin, a commonly prescribed medication for diabetes. The synergy between these polyphenol-rich extracts and metformin offers a promising avenue for improving diabetes management, potentially leading to better patient outcomes.
We are incredibly proud of our dedicated R&D team, whose hard work and commitment have been instrumental in achieving this milestone. This accomplishment underscores our relentless pursuit of innovative healthcare solutions and solidifies our position as leaders in cutting-edge research.
We extend our heartfelt thanks to our team members—Barbara Khaidakov, Katarzyna Zima, Laura Banaszkiewicz, Paulina Karolina Kowalczyk, and Krzysztof Lemke—whose expertise and passion have driven this success. Together, we will continue to push the boundaries of scientific discovery and make meaningful strides in the management of diabetes.
